Phase 2 Study of AMG 386 Plus Paclitaxel With or Without Bevacizumab as First Line Therapy in Her2-Negative Breast Cancer Patients

Clinical trial NCT00511459 · COMPLETED

Trial details

NCT number: NCT00511459
Sponsor: Amgen
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Locally Recurrent and Metastatic Breast Cancer

Start date: 2007-07-01
Primary completion: 2010-08-01
Enrollment: 228

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.